Technical Analysis for SYRE - Spyre Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 33.56 | 3.36% | 1.09 |
SYRE closed up 3.36 percent on Friday, April 26, 2024, on 43 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Stochastic Buy Signal | Bullish | 3.36% | |
| Bollinger Band Squeeze | Range Contraction | 3.36% | |
| NR7 | Range Contraction | 3.36% | |
| Doji - Bullish? | Reversal | 3.36% | |
| Lower Bollinger Band Walk | Weakness | 3.36% | |
| BB Squeeze + Lower Band Touch | Range Contraction | 3.36% |
| Alert | Time |
|---|---|
| 10 DMA Resistance | about 17 hours ago |
| Up 5% | about 17 hours ago |
| Possible NR7 | about 18 hours ago |
| 60 Minute Opening Range Breakout | about 20 hours ago |
| Up 3% | about 22 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Spyre Therapeutics is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immunology Antibodies Autoimmune Disease Monoclonal Antibody Antibody Inflammatory Bowel Disease
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immunology Antibodies Autoimmune Disease Monoclonal Antibody Antibody Inflammatory Bowel Disease
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 47.97 |
| 52 Week Low | 2.66 |
| Average Volume | 530,760 |
| 200-Day Moving Average | 20.47 |
| 50-Day Moving Average | 34.61 |
| 20-Day Moving Average | 35.55 |
| 10-Day Moving Average | 34.23 |
| Average True Range | 2.93 |
| RSI (14) | 45.05 |
| ADX | 18.46 |
| +DI | 18.12 |
| -DI | 19.62 |
| Chandelier Exit (Long, 3 ATRs) | 32.06 |
| Chandelier Exit (Short, 3 ATRs) | 40.05 |
| Upper Bollinger Bands | 39.67 |
| Lower Bollinger Band | 31.43 |
| Percent B (%b) | 0.26 |
| BandWidth | 23.17 |
| MACD Line | -0.73 |
| MACD Signal Line | -0.16 |
| MACD Histogram | -0.5702 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 36.28 | ||||
| Resistance 3 (R3) | 36.22 | 35.26 | 35.82 | ||
| Resistance 2 (R2) | 35.26 | 34.57 | 35.29 | 35.67 | |
| Resistance 1 (R1) | 34.41 | 34.14 | 34.84 | 34.47 | 35.52 |
| Pivot Point | 33.45 | 33.45 | 33.67 | 33.48 | 33.45 |
| Support 1 (S1) | 32.60 | 32.76 | 33.03 | 32.66 | 31.60 |
| Support 2 (S2) | 31.64 | 32.33 | 31.67 | 31.45 | |
| Support 3 (S3) | 30.79 | 31.64 | 31.30 | ||
| Support 4 (S4) | 30.85 |
